ATP

Veo Technologies ApS specializes in developing video technology that enables the automatic recording and analysis of football matches without the need for a cameraman. Founded in 2015 and based in Copenhagen, Denmark, the company provides a solution that allows clubs, players, coaches, scouts, families, and fans to capture and share high-quality sports footage easily. Veo's platform uses two action cameras that automatically track player and ball movement, producing complete video recordings of matches. This technology eliminates the need for manual video editing, making it accessible and affordable for football clubs of all sizes to stream and review their games.

MedTrace Pharma A/S is a medical device company based in Kongens Lyngby, Denmark, with additional offices in Boston, Massachusetts, and Uppsala, Sweden. Founded in 2015, the company specializes in the development of innovative solutions for positron emission tomography (PET) imaging. Its flagship product, the MT-100, is an automated system designed for on-site production and infusion of the tracer 15O-water, which enhances the sensitivity of PET scans and improves patient throughput. MedTrace also offers aQuant, an analytical platform that interprets the PET scan results, enabling physicians to obtain accurate blood flow measurements in various clinical applications, including heart studies and tumor vascularization. The integration of these technologies aims to revolutionize PET diagnostic imaging by providing safer and more efficient tools for healthcare professionals.

Visiopharm A/S specializes in AI-based image analysis and tissue mining tools for the pathology sector. Founded in 2001 and headquartered in Horsholm, Denmark, with additional offices in Germany, Sweden, the United Kingdom, and the USA, the company offers a comprehensive range of digital pathology solutions. These include the Oncotopix scanner for capturing digital slide images and a suite of AI applications designed for diagnostic and clinical research. Key software features include the Visiopharm Viewer for advanced image analysis, an AI Phenotyping module for automating image data workflows, and the Tissuealign module for analyzing digitalized serial sections. Visiopharm's products are widely utilized by biopharmaceutical companies, research organizations, and hospitals, with over 500 licenses in more than 30 countries. The company's solutions have been validated through over 800 scientific publications and are compatible with various slide scanners and microscopy equipment, enhancing productivity and standardization in tissue data analysis.

Visiopharm A/S specializes in AI-based image analysis and tissue mining tools for the pathology sector. Founded in 2001 and headquartered in Horsholm, Denmark, with additional offices in Germany, Sweden, the United Kingdom, and the USA, the company offers a comprehensive range of digital pathology solutions. These include the Oncotopix scanner for capturing digital slide images and a suite of AI applications designed for diagnostic and clinical research. Key software features include the Visiopharm Viewer for advanced image analysis, an AI Phenotyping module for automating image data workflows, and the Tissuealign module for analyzing digitalized serial sections. Visiopharm's products are widely utilized by biopharmaceutical companies, research organizations, and hospitals, with over 500 licenses in more than 30 countries. The company's solutions have been validated through over 800 scientific publications and are compatible with various slide scanners and microscopy equipment, enhancing productivity and standardization in tissue data analysis.